Currently, 7.6% of the U.S. young adults aged 18–24 years old use e-cigarettes. This study piloted three methods of Electronic Nicotine Delivery Systems (ENDS) cessation by measuring cessation rates, motivational techniques that contributed to cessation success, and participants’ changes after decreasing vape use. Participants were randomized into three study arms (nicotine replacement therapy (NRT) + behavioral support, vape-taper + behavioral support, self-guided) in a 1:1:1 ratio. All participants were invited to attend nine in-person or phone appointments over the 6-month study period. At 12 weeks, 3 of 7 (42.9%) participants in the NRT + behavioral support arm, 6 of 8 (75%) vape-taper + behavioral support arm, and 7 of 9 (77.8%) self-guided arm self-reported being vape-free and nicotine-free. At 6 months, 3 of 7 (42.9%) participants in the NRT + behavioral support arm, 6 of 8 (75%) vape-taper + behavioral support arm, and 4 of 9 (44.4%) self-guided arm self-reported being vape-free and nicotine-free. A challenge to quitting and remain quit is social pressures, but participants identified self-control and establishing new habits to be the best methods to overcome the desire to vape. Participants who received behavioral support and a vape-taper plan from pharmacists were more likely to be vape-free and nicotine-free at 6 months.
Tapering of vaping, reducing nicotine concentration and restricting vaping times, coupled with behavioral counseling may be effective for cessation of electronic nicotine delivery system use.
1 July 2021 in Journal of the American Pharmacists Association
Background: Electronic Nicotine Delivery Systems (ENDS) have seen increased use in the past several years with no clear guide for healthcare providers to help motivated users to quit. Case Study: 25-year-old African American male who had been vaping since 2015 started using nicotine replacement therapy and received behavioral support by a pharmacist to help quit. Conclusion: Nicotine replacement therapy paired with behavioral counseling could be beneficial to ENDS users by reducing withdrawal symptoms and helping them quit.